The human heart serves to pump oxygenated blood to every corner of the body, beating 100,000 times a day. Adverse conditions such as increased blood pressure or heart attack causes cardiac muscle damage, decreasing its pumping capacity. This is called cardiomyopathy.
To compensate for this anomaly, the heart works harder. This increases the ventricle size leading to a large, round shaped heart, called dilated cardiomyopathy. To prevent or reverse the dilation, the volume of the ventricle must be reduced by thickening its walls.
For this purpose, the pioneer treatment by Lonestar Heart called Algisyl
is introduced. It is an implantable hydrogel based on marine algae. Available in minimally invasive catheter delivery system, Algisyl is injected into the muscle wall. As clearly shown in the animation, the highly compatible Algisyl reverses the cardiomyopathy; hence, reducing wall tension, improving
contractility and decreasing clinical symptoms of advanced heart failure.